Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calpastatin is the endogenous, specific inhibitor of the calpain family of calcium-dependent cysteine proteases. The human calpastatin protein, encoded by the CAST gene, contains one N-terminal regulatory domain and four repetitive calpain-inhibition domains. It tightly controls calpain activity, which is critical for cellular functions including cytoskeletal remodeling, signal transduction, membrane fusion events, cell cycle progression, and apoptosis. Calpastatin acts by reversible, calcium-dependent binding and inhibition of calpain, uniquely blocking the protease without itself being cleaved, through a novel domain conformational mechanism. Dysregulation of calpastatin or calpain activity is implicated in diseases such as muscular dystrophy, skin disorders, cancer, and neurodegenerative diseases.
Competitive inhibition of calpain active site in a calcium-dependent manner. Occupies calpain active site cleft to block substrate access, escapes cleavage by a novel looping mechanism.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calpastatin (CAST).